期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Comprehensive and updated review on the diagnosis and treatment of Vogt-Koyanagi-Harada disease
1
作者 Charlene H.Choo Nisha R.Acharya Jessica G.Shantha 《Annals of Eye Science》 2023年第2期39-52,共14页
The purpose of this review is to provide a comprehensive and updated overview of the clinical features,imaging modalities,differential diagnosis,diagnostic criteria,and treatment options for Vogt-Koyanagi-Harada(VKH)s... The purpose of this review is to provide a comprehensive and updated overview of the clinical features,imaging modalities,differential diagnosis,diagnostic criteria,and treatment options for Vogt-Koyanagi-Harada(VKH)syndrome,a rare progressive inflammatory condition characterized by bilateral granulomatous panuveitis and systemic manifestations.While the clinical features and disease course of VKH syndrome are well-characterized in the literature,its diagnosis is challenging due to a broad differential that include infectious and noninfectious causes of uveitis and rare inflammatory conditions,as well as a lack of a single diagnostic finding on exam,laboratory testing,or imaging.The evolution of the diagnostic criteria for VKH syndrome reflects the growing understanding of the disease by the ophthalmic community and advancement of imaging technology.Findings on enhanced depth imaging(EDI)optical coherence tomography(OCT)and indocyanine green angiography(ICGA)help detect subtle inflammation of the choroid and were incorporated into new diagnostic criteria developed in the last few years.There is limited research on the treatment for acute VKH,but results of studies to date support the early initiation of immunomodulatory therapy(IMT)due to a high recurrence rate and progression to chronic disease in patients treated with monotherapy with high-dose systemic corticosteroids.This review will provide an indepth summary of recent literature on advanced imaging modality and IMT to guide clinicians in their management of patients with VKH syndrome. 展开更多
关键词 Vogt-Koyanagi-Harada(VKH) UVEITIS AUTOIMMUNE multimodal imaging
下载PDF
单一大剂量抗生素在传染性沙眼流行中的作用
2
作者 Chidambaram J.D. Alemayehu W. +2 位作者 Melese M. T.M. Lietman 潘佳鸿 《世界核心医学期刊文摘(眼科学分册)》 2006年第8期5-6,共2页
Context: The World Health Organization recommends mass antibiotic distributions in its strategy to eliminate blinding trachoma as a public health concern. Some hypothesize that a single distribution is sufficient to c... Context: The World Health Organization recommends mass antibiotic distributions in its strategy to eliminate blinding trachoma as a public health concern. Some hypothesize that a single distribution is sufficient to control the ocular strains of chlamydia that cause trachoma. Others believe infection will inevitably return and periodic treatments or other measures are essential. Objective: To determine whether ocular chlamydial infection returns to the community up to 24 months after a single mass antibiotic distribution in a hyperendemic region of Ethiopia. Design, Setting, and Participants: Longitudinal cohort study conducted March 2003 to March 2005 in the Gurage Zone of Ethiopia. Eight randomly selected villages were assessed for ocular chlamydial infection. Fifteen untreated villages were randomly chosen at 12 months to allow assessment of a secular trend. Intervention A single dose of oral azithromycin was offered to all residents of the 8 selected villages who were aged 1 year or older. Main Outcome Measure: Prevalence of ocular chlamydial infection in all children aged 1 to 5 years from each intervention village prior to treatment and 2, 6, 12, 18, and 24 months after mass antibiotic treatment, and also in untreated villages enrolled at 12 months. Results: Five hundred fifteen children were examined for ocular chlamydial infection at baseline. For the followup examinations, the mean participation rate was 83% . The mean prevalence of infection in children aged 1 to 5 years decreased from 43.5% (95% confidence interval [CI]35.0% - 52.0% ) to 5.1% (95% CI, 1.1% - 9.2% ) after treatment. On average, infection returned gradually over 24 months to 11.3% (95% CI, 4.5% - 18.1% ; P=.001). In 7 of 8 villages, infection was higher at 24 months than at 2 months. In the remaining village, no infection could be identified at any point after treatment. Villages enrolled at 12 months had significantly fewer infections than those enrolled 12 months earlier, suggesting a secular trend (P< .001). Conclusions: Ocular chlamydial infection was not eliminated in children aged 1 to 5 years after a single mass azithromycin distribution; it slowly returned over 24 months, although not to baseline levels. Repeated treatments or other effective measures will be necessary for elimination. 展开更多
关键词 大剂量抗生素 衣原体感染 公共卫生事业 阿齐霉素 队列研究 基线水平 趋势评估 随访检查
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部